Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.94% |
| 2 | Technology | 1.79% |
| 3 | Consumer Discretionary | 0.82% |
| 4 | Financials | 0.79% |
| 5 | Healthcare | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
PUT
CDW
CDW
$18.6B
| $9.86M | ﹤0.01% |
55,200
-10,900
| -16% | -$1.85M |
|
2852
CALL
Cytokinetics
CYTK
$10.8B
| $9.85M | ﹤0.01% |
298,100
+48,000
| +19% | +$1.67M |
|
2853
PUT
Immersion
IMMR
$259M
| $9.84M | ﹤0.01% |
1,248,800
+111,900
| +10% | +$832K |
|
2854
CALL
FirstEnergy
FE
$26.8B
| $9.83M | ﹤0.01% |
244,100
-7,900
| -3% | -$326K |
|
2855
Capri Holdings
CPRI
$1.5B
| $9.83M | ﹤0.01% |
555,171
-232,290
| -29% | -$3.83M |
|
2856
CALL
Kinsale Capital Group
KNSL
$8.7B
| $9.82M | ﹤0.01% |
20,300
-13,300
| -40% | -$6.2M |
|
2857
PUT
Xcel Energy
XEL
$48.2B
| $9.82M | ﹤0.01% |
144,200
+55,300
| +62% | +$3.83M |
|
2858
Valley National Bancorp
VLY
$7.71B
| $9.81M | ﹤0.01% |
1,098,636
-185,134
| -14% | -$1.61M |
|
2859
CALL
Lennox International
LII
$13.5B
| $9.8M | ﹤0.01% |
17,100
-1,200
| -7% | -$671K |
|
2860
BHP
BHP
$245B
| $9.8M | ﹤0.01% |
203,690
-63,463
| -24% | -$3.05M |
|
2861
CALL
Corebridge Financial
CRBG
$14.5B
| $9.79M | ﹤0.01% |
275,900
-29,800
| -10% | -$927K |
|
|
MSTU
2862
T-Rex 2X Long MSTR Daily Target ETF
MSTU
$6.67B
| $9.79M | ﹤0.01% |
+11,321
| New | +$8.56M |
|
2863
Texas Pacific Land
TPL
$25.5B
| $9.78M | ﹤0.01% |
27,768
+12,924
| +87% | +$5.28M |
|
2864
Corteva
CTVA
$55B
| $9.78M | ﹤0.01% |
131,177
+71,521
| +120% | +$4.76M |
|
|
SEZL
2865
PUT
Sezzle
SEZL
$4.24B
| $9.77M | ﹤0.01% |
+54,500
| New | +$4.82M |
|
2866
CALL
Medifast
MED
$136M
| $9.77M | ﹤0.01% |
695,200
+508,500
| +272% | +$6.68M |
|
2867
Dimensional Emerging Markets Value ETF
DFEV
$2.14B
| $9.77M | ﹤0.01% |
325,631
+247,507
| +317% | +$6.87M |
|
|
SPYM
2868
State Street SPDR Portfolio S&P 500 ETF
SPYM
$171B
| $9.76M | ﹤0.01% |
134,245
+115,815
| +628% | +$7.79M |
|
|
GRRR
2869
CALL
Gorilla Technology Group
GRRR
$431M
| $9.75M | ﹤0.01% |
490,300
+8,500
| +2% | +$159K |
|
2870
CALL
ARK Genomic Revolution ETF
ARKG
$1.96B
| $9.75M | ﹤0.01% |
400,300
-116,200
| -22% | -$2.55M |
|
2871
VSE Corp
VSEC
$6.2B
| $9.74M | ﹤0.01% |
74,353
-3,215
| -4% | -$401K |
|
2872
CALL
Middleby
MIDD
$5.14B
| $9.71M | ﹤0.01% |
67,400
+17,400
| +35% | +$2.45M |
|
2873
PUT
YieldMax NVDA Option Income Strategy ETF
NVDY
$1.43B
| $9.7M | ﹤0.01% |
578,500
+160,000
| +38% | +$2.48M |
|
|
CCC
2874
CCC Intelligent Solutions
CCC
$4.48B
| $9.69M | ﹤0.01% |
1,030,184
-635,013
| -38% | -$5.68M |
|
2875
PUT
Inspire Medical Systems
INSP
$1.76B
| $9.69M | ﹤0.01% |
74,700
+12,400
| +20% | +$1.8M |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2025 filing shows 1,720 new, 5,716 increased, 5,055 reduced and 1,538 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.